• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Egyptian Journal of Clinical Ophthalmology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 8 (2025)
Volume Volume 7 (2024)
Volume Volume 6 (2023)
Volume Volume 5 (2022)
Issue Issue 2
Issue Issue 1
Volume Volume 4 (2021)
Volume Volume 3 (2020)
Volume Volume 2 (2019)
Volume Volume 1 (2018)
H., M., M., H., O., A., H., H., A., A., M., A., I., A. (2022). CORRELATION BETWEEN SERUM MELATONIN LEVEL AND OTHER INDICATORS WITH STAGES OF DIABETIC RETINOPATHY. Egyptian Journal of Clinical Ophthalmology, 5(2), 151-160. doi: 10.21608/ejco.2022.280978
Mahmoud, H.; Hashim, M.; Ahmed, O.; Hefny, H.; Ali, A.; Anbar, M.; Awny, I.. "CORRELATION BETWEEN SERUM MELATONIN LEVEL AND OTHER INDICATORS WITH STAGES OF DIABETIC RETINOPATHY". Egyptian Journal of Clinical Ophthalmology, 5, 2, 2022, 151-160. doi: 10.21608/ejco.2022.280978
H., M., M., H., O., A., H., H., A., A., M., A., I., A. (2022). 'CORRELATION BETWEEN SERUM MELATONIN LEVEL AND OTHER INDICATORS WITH STAGES OF DIABETIC RETINOPATHY', Egyptian Journal of Clinical Ophthalmology, 5(2), pp. 151-160. doi: 10.21608/ejco.2022.280978
H., M., M., H., O., A., H., H., A., A., M., A., I., A. CORRELATION BETWEEN SERUM MELATONIN LEVEL AND OTHER INDICATORS WITH STAGES OF DIABETIC RETINOPATHY. Egyptian Journal of Clinical Ophthalmology, 2022; 5(2): 151-160. doi: 10.21608/ejco.2022.280978

CORRELATION BETWEEN SERUM MELATONIN LEVEL AND OTHER INDICATORS WITH STAGES OF DIABETIC RETINOPATHY

Article 11, Volume 5, Issue 2, December 2022, Page 151-160  XML PDF (444.74 K)
Document Type: Original articles: include clinical trials, interventional research, Basic researches and clinically relevant laboratory investigations
DOI: 10.21608/ejco.2022.280978
View on SCiNiTO View on SCiNiTO
Authors
Mahmoud, H.1; Hashim, M.2; Ahmed, O.3; Hefny, H.4; Ali, A.5; Anbar, M.1; Awny, I.1
1Ophthalmology dept., Faculty of Medicine, Sohag, Univ., Egypt
2Biochemistry dept., Faculty of Medicine, Sohag, Univ., Egypt
3Internal Medicine dept., Faculty of Medicine, Sohag, Univ., Egypt
4Clinical Pathology dept., Faculty of Medicine, Sohag, Univ., Egypt
5Microbiology and Immunology dept., Faculty of Medicine, Aswan, Univ., Egypt
Abstract
Purpose: Diabetic retinopathy is considered the ghost cause of vision deterioration; it is attributed to elevated oxidative stress. Antioxidants, like melatonin, were found to be affected in
diabetic retinopathy. In the present paper, we aim to explore melatonin levels in various stages of
diabetic retinopathy.
Method: Patients with diabetic retinopathy were recruited and divided into 3
groups (non-proliferative diabetic retinopathy (NPDR), proliferative diabetic retinopathy (PDR), and
advanced diabetic eye disease). One control group was recruited (diabetics without diabetic
retinopathy). Each participant was subjected to full ophthalmological examination, internal medicine evaluation, fluorescein angiography F/A, as well as optical coherence tomography (OCT) to
classify the stage of diabetic retinopathy. The laboratory evaluation of melatonin, bilirubin, aspartate transferase AST, alanine transferase ALT, fasting plasma glucose FBG, hemoglobin A1c
HA1c, and lipid profile were done. Data were collected and analyzed.
Results: Each group < br />includes 60 participants. We found no different sex distribution in the four groups as (P value
=0.77), age in the four groups was as follows 58.35±8.56, 55.77±14.43, 59.3±10.73, 60.98±
7.60 years with (P =0.06). For diabetes-associated variables like duration, fasting glucose
levels, HA1c, and medications (insulin or oral hypoglycemic), we found this result; increased
duration of diabetes with raised levels of FBG, HA1C, and insulin treatment were linked with
severe diabetic retinopathy affection (P value <0.0001). When assessing the plasma melatonin
levels, the mean melatonin levels were decreased significantly with increased severity of diabetic
retinopathy (86.04 ± 2.71, 73.05 ± 6.91, 25.82 ± 2.89, 24.28 ± 2.37 pg/ml) in the studied groups
NDR, NPDR, PDR and advanced diabetic retinopathy with (P-value < 0.0001). Decreased
melatonin could be a risk factor for diabetic retinopathy. As regards total bilirubin, its mean values
decreased significantly with increasing severity of DR (P-value < 0.0001).
Conclusion: There
is a relation between the levels of serum melatonin and the severity of diabetic retinopathy.


Keywords
NPDR; PDR; Melatonin; HA1c; Bilirubin
Statistics
Article View: 1,081
PDF Download: 862
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.